A Phase I Study of BMS-641988 in Japanese Patients With Castration Resistant Prostate Cancer.
Phase of Trial: Phase I
Latest Information Update: 07 Aug 2009
At a glance
- Drugs BMS 641988 (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 31 Aug 2018 Biomarkers information updated
- 07 Aug 2009 Actual patient number changed from 6 to 7 as reported by ClinicalTrials.gov.
- 08 May 2009 Actual number of patients added as 6 as reported by ClinicalTrials.gov.